Galectin Therapeutics (PHPN.F) Q4 2025 Earnings

14NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-0.19
-0.16
-0.13
-0.09

Details

Expected EPS
-0.094633
Actual EPS
-0.111839
Surprise EPS
-0.02
Surprise Percent
+18.18%

Description

Galectin Therapeutics (PHPN.F) has reported earnings of -0.111839 per share for Q4 2025.

0 Comments

Share your thoughts